phosphoserine has been researched along with sphingosine 1-phosphate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellan, J; Chap, H; Gaigé, B; Grévy, JM; Gueguen, G; Klaébé, A; Pont, F; Rogalle, P; Simon, MF; Wilson, M | 1 |
| Clemens, JJ; Davis, MD; Lynch, KR; Macdonald, TL | 1 |
| Aiba, A; Jona, M; Kassai, H; Kurano, M; Morimoto, Y; Nakao, K; Shimizu, T; Tsuneyama, K; Yatomi, Y | 1 |
| Dokuni, R; Kamiryo, H; Katsurada, M; Kawa, Y; Kobayashi, K; Nagano, T; Nishimura, Y; Terashita, T; Umezawa, K; Yamamoto, M; Yasuda, Y; Yoshizaki, A | 1 |
| Jing, X; Li, Y; Liu, B; Liu, Y; She, Q | 1 |
5 other study(ies) available for phosphoserine and sphingosine 1-phosphate
| Article | Year |
|---|---|
Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Topics: Humans; Lysophospholipids; Palmitates; Phosphoserine; Platelet Aggregation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Sphingosine; Structure-Activity Relationship | 1999 |
Sphingosine 1-phosphate analogs as receptor antagonists.
Topics: Calcium; Cell Line; Cell Membrane; Cell Movement; Dose-Response Relationship, Drug; Drug Design; Fingolimod Hydrochloride; Guanosine Triphosphate; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Lipids; Lymphocytes; Lysophospholipids; Models, Chemical; Phosphoserine; Propylene Glycols; Protein Binding; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Structure-Activity Relationship; Transfection | 2005 |
Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury.
Topics: Alanine Transaminase; Animals; Apolipoproteins M; Clustered Regularly Interspaced Short Palindromic Repeats; Creatinine; Disease Models, Animal; Disseminated Intravascular Coagulation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipopolysaccharides; Lipoproteins, HDL; Lysophospholipids; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; Phosphoserine; Receptors, Lysosphingolipid; Sepsis; Sphingosine | 2018 |
Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchi; Cell Line; Chemokine CCL20; Disease Models, Animal; Eosinophilia; Epithelial Cells; Female; Gene Expression; Gene Knockdown Techniques; Humans; Lysophospholipids; Mice; Mice, Inbred BALB C; Phosphoserine; Receptors, Adrenergic, beta-2; Receptors, Lysosphingolipid; Receptors, Prostaglandin E, EP4 Subtype; Sphingosine; Sphingosine-1-Phosphate Receptors | 2018 |
Sphingosine 1-phosphate induces epicardial progenitor cell differentiation into smooth muscle-like cells.
Topics: Actins; Animals; Cell Differentiation; Cells, Cultured; Gene Expression Regulation; Lysophospholipids; Mice; Mice, Inbred C57BL; Mouse Embryonic Stem Cells; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pericardium; Phosphoserine; Pyrazoles; Pyridines; Receptors, Lysosphingolipid; Sphingosine | 2019 |